• The Latest AI Can Work Things Out Without Being Taught

    Oct 18, 2017, 17:02 PM by Michael Croft
    The Economist | IN 2016 Lee Sedol, one of the world's best players of Go, lost a match in Seoul to a computer program called AlphaGo by four games to one. It was a big event, both in the history of Go and in the history of artificial intelligence.
    Full story
  • How To Spend $1900 On Gene Tests Without Learning A Thing

    Oct 18, 2017, 09:15 AM by Michael Croft
    MIT Technology Review | Science and marketing clash in the "jungle" of direct-to-consumer DNA apps.
    Full story
  • What’s new at Lab Innovations 2017

    Oct 18, 2017, 03:53 AM by Michael Croft
    BIRMINGHAM, ENGLAND - Oct 18, 2017 - Now in its sixth consecutive year, the showcase promises an array of new and exciting attractions for 2017, developed to cater to the broad needs of visitors to the UK’s only dedicated event for laboratory, analytical and biotech equipment
    Full story
  • New European Council of regulatory professionals set to shape and support the profession

    Oct 17, 2017, 11:34 AM by Michael Croft
    - Oct 17, 2017 - The Regulatory Affairs Professionals Society (RAPS) is stepping up its presence in Europe and supporting its European expansion with the launch of its first ever RAPS European Council (REC)
    Full story
  • GA4GH Announces New Strategic Plan, Vision To Create Standards

    Oct 17, 2017, 11:00 AM by Michael Croft

    Bio-IT World | At a plenary session this morning in Orlando, Florida, the Global Alliance for Genomics and Health (GA4GH) announced a new vision and five-year strategic plan: GA4GH Connect, aiming to drive uptake of GA4GH standards and frameworks for genomic data discovery, analysis, and interpretation in order to enable responsible sharing of clinical-grade genomic data by 2022.

    Full story
  • China Welcomes Oxford Nanopore Technology

    Oct 17, 2017, 10:45 AM by Michael Croft

    Bio-IT World Brief | Oxford Nanopore sequencing technology is now available in China. The long-read, real-time, portable MinION sequencer is now being used by researchers across China, who are working on myriad DNA sequencing applications including: pathogen research, human genetics, plant genetics, animal genetics, and metagenomics.

    Full story
  • BC Platforms Announces Collaborations to Advance Research in Multiple Sclerosis

    Oct 17, 2017, 08:03 AM by Michael Croft
    BASEL, SWITZERLAND AND BOSTON, MASSACHUSETTS - Oct 16, 2017 - BC Platforms, a world leader in genomic data management and analysis solutions, today announces that Biogen and the Accelerated Cure Project (ACP) will each be using its technology solutions and research platform, including its recently launched BCRQUEST
    Full story
  • Illumina Ventures Closes $230 Million Fund

    Oct 16, 2017, 12:10 PM by Michael Croft

    Bio-IT World Brief | Illumina Ventures announced today that it has raised $230 million for its first fund. The balance of the funds have been raised from a mix of corporate, institutional, sovereign, and individual investors.

    Full story
  • Intercept (ICPT) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH

    Oct 13, 2017, 14:50 PM by Michael Croft
    CHAPEL HILL, NC - Oct 13, 2017 - TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Intercept has extended its strategic partnership for TARGET-NASH to a multi-year agreement
    Full story
  • Data Security And Cloud Providers: Assessing The Risks

    Oct 13, 2017, 11:15 AM by Michael Croft

    Bio-IT World Contributed Commentary | Research organizations are aware of the potential for cloud technologies to increase efficiency, cut costs, and reduce time to market. In the wake of the recent Equifax breach, the latest in a seemingly endless string of security incidents, organizations want to ensure they are protecting their assets and minimizing potential liabilities.

    Full story
  • Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASH

    Oct 12, 2017, 11:24 AM by Michael Croft
    CHAPEL HILL, NC - Oct 12, 2017 - TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Bristol-Myers Squibb (BMY) has extended its strategic partnership for TARGET-NASH to a multi-year agreement
    Full story
  • FDA Vote Sets Stage For Gene Therapy’s Future

    Oct 12, 2017, 09:14 AM by Michael Croft
    MIT Technology Review | A first-of-its-kind medical treatment that replaces a mutated gene with a correct copy could soon be available in the U.S.
    Full story
  • Elsevier donates Unified Data Model to The Pistoia Alliance, facilitating data sharing and accelerating research in the life sciences

    Oct 12, 2017, 05:03 AM by Michael Croft
    NEW YORK, NY - Oct 10, 2017 - Elsevier, the information analytics business specializing in science and health, has announced it is donating its Unified Data Model (UDM) to The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D
    Full story
  • MDI Biological Laboratory Scientist Vicki P. Losick, Ph.D., Recognized As ‘Outstanding Investigator’

    Oct 11, 2017, 15:49 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Oct 11, 2017 - Vicki P. Losick, Ph.D., of the MDI Biological Laboratory in Bar Harbor, Maine, has been recognized as an “outstanding investigator” by the National Institute of General Medical Sciences, an institute of the National Institutes of Health (NIH), for her research on wound healing
    Full story
  • The Future Of DNA Sequencing

    Oct 11, 2017, 13:26 PM by Michael Croft
    Nature News & Comment | Eric D. Green, Edward M. Rubin, and Maynard V. Olson speculate on the next forty years of DNA sequencing, from policing to data storage.
    Full story
  • What The EU General Data Protection Regulation Means For You

    Oct 10, 2017, 09:15 AM by Michael Croft

    Bio-IT World | The European Union’s General Data Protection Regulation goes into effect May 25, 2018. The regulation is significantly more expansive than the privacy directive it replaces and carries hefty financial penalties for non-compliance. But the biggest cause for concern may be its impact for non-European companies, who have no idea that the regulations apply to them.

    Full story
  • Optibrium Joins EUR 40 Million eTRANSAFE project

    Oct 10, 2017, 06:02 AM by Michael Croft
    CAMBRIDGE, UK - Oct 10, 2017 - Optibrium™, a developer of software for small molecule drug discovery, today announced that it will join the Enhancing Translational Safety Assessment through Integrative Knowledge Management (eTRANSAFE) project
    Full story
  • Launch of Next-Generation Clinical Trial Data Platform

    Oct 10, 2017, 01:25 AM by Michael Croft
    RUTLAND, MA, UNITED STATES - Oct 10, 2017 - A brand new clinical trial database and collaborative platform was launched on the 3rd of October, with the aim of being the leading source for every clinical trial data need
    Full story
  • 4D Movies Reveal Two Mechanisms For DNA Loops

    Oct 6, 2017, 10:40 AM by Michael Croft

    Bio-IT World | A paper published yesterday in Cell sheds more light on two mechanisms of DNA folding within the nucleus, and how the folding impacts genome function.

    Full story
  • Illumina Introduces Nextera DNA Flex

    Oct 6, 2017, 08:40 AM by Michael Croft

    Bio-IT World Brief | Illumina announced the availability of an innovative whole genome sequencing library prep product, Nextera DNA Flex, which eliminates the need for sample preparation for whole blood and saliva, and removes tedious steps in the library prep workflow, such as mechanical fragmentation of DNA, quantification, and normalization.

    Full story